Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1989
Effect of intracoronary nicardipine on methylergonovine-induced coronary artery spasm in patients with variant anginaM E Bertrand, J M La Blanche, P Hudon, et al.
Journal of Pharmaceutical Sciences|November 1, 1989
Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administrationB A Boucher, A M Bombassaro, S N Rasmussen, et al.
Journal of Clinical Pharmacology|August 1, 1987
Esmolol-digoxin drug interactionD T Lowenthal, R S Porter, R Achari, et al.
Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonistR Achari, D Drissel, J D Hulse, et al.
American Heart Journal|February 1, 1990
Nicardipine versus placebo for the treatment of postoperative hypertensionM E Goldberg, S Clark, J Joseph, et al.
Clinical Pharmacology and Therapeutics|April 29, 1998
Pharmacodynamics and pharmacokinetics of DMP 728, a platelet GPIIb/IIIa antagonist, in healthy subjectsW Michaelis, P Turlapaty, J Gray, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1989
Changes of plasma renin activity and atrial natriuretic factor during intravenous nicardipine treatment of severe hypertensionG G Clifton, M E Cook, P MacCarthy, et al.
The American Journal of Medicine|September 1, 1988
Intravenous nicardipine for the treatment of severe hypertensionJ D Wallin, M E Cook, L Blanski, et al.
Journal of Clinical Pharmacology|March 1, 1988
Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blockerJ Strom, M Josephson, W H Frishman, et al.
Pageof 3